187 results
Page 4 of 10
8-K
EX-99
teofc14g
28 Apr 14
Financial Statements and Exhibits
12:00am
8-K
EX-99.1
1ph4ndclc yga
22 Apr 14
Breo™Ellipta® (fluticasone furoate/vilanterol trifenatate) approved in Australia for Asthma and Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-10.2
jakgpbk wissxlrwnk
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.8
8mnmm
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
nt0al3cpnxv2tq2j
9 Apr 14
Regulation FD Disclosure
12:00am
8-K
EX-99
b8oy1zvq730c6pdc1e
13 Mar 14
Other Events
12:00am
8-K
EX-99
ka4 9p1dcckjqi
6 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
4s8za2f9bhv
9 Jan 14
ANORO™ ELLIPTA™ approved for COPD treatment in Canada
12:00am
8-K
EX-99.1
4o0dhzo og
18 Dec 13
Other Events
12:00am
8-K
EX-99
a0bd3u7ss5n
6 Dec 13
Other Events
12:00am
8-K
EX-99
ic9 34wfmunzib
30 Oct 13
Other Events
12:00am
8-K
EX-99
zna7i3u3o761
10 Sep 13
Regulation FD Disclosure
12:00am
8-K
EX-99.2
hrjbgr
9 Sep 13
Other Events
12:00am
8-K
EX-99.1
pjs9 9yvcbn6jmdtu9
3 Jun 13
Regulation FD Disclosure
12:00am